Literature DB >> 19326099

The anti-arrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function.

Jennifer A Easton1, Jorgen S Petersen, Patricia E M Martin.   

Abstract

The anti-arrhythmic peptide AAP10 has previously been shown to acutely upregulate electrical cell-to-cell coupling mediated via connexin 43 gap junctions. In the present work, we have further examined the connexin (Cx) specificity and mechanism of action of this peptide in HeLa cells expressing Cx43, Cx40 or Cx26. The ability of cells to transfer the small fluorescent dyes Alexa 488 (MW 570) or Alexa 594 (MW 759), as markers for metabolic coupling mediated via gap junctions, before and after exposure to AAP10 and/or the protein kinase C inhibitor chelerythrine for 5 h was determined by microinjection analysis. Immunofluorescence analysis assessed the effect of AAP10 on the spatial localisation of each Cx sub-type. Cell extracts were isolated for Western blot and reverse transcription polymerase chain reaction analysis at 0, 5, 10, 18 and 24 h following exposure to AAP10 and the relative Cx expression profiles determined. AAP10 enhanced the ability of Cx43 and, to a lesser extent, Cx40 to transfer Alexa 488. It also enhanced the ability of Cx43 to transfer Alexa 594 but not Cx40. Inhibition of protein kinase C blocked this enhanced response in both Cx sub-types. Western blot analysis determined that AAP10 induced Cx40 protein expression over periods of up to 24 h with an associated increase in the localisation of Cx40 at points of cell-to-cell contact following 24-h exposure. Cx43 expression was transiently induced following exposure to the peptide for 5-10 h, with an associated increase in Cx43 at points of cell-to-cell contact, returning to control levels by 18-24 h, via a post-translational mechanism independent of chelerythrine. A transient increase in Cx40 mRNA expression but not Cx43 mRNA expression was also observed. By contrast, AAP10 had no effect on the ability of Cx26 gap junctions to transfer the dyes or on the level of Cx26 expression. We propose that AAP10 is a versatile peptide that remodels metabolic coupling via Cx43 and to a lesser extent Cx40 gap junction channels via an initial protein-kinase-C-dependent pathway modifying local responses at the plasma membrane. This is followed by enhanced Cx43 or Cx40 protein expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326099     DOI: 10.1007/s00210-009-0411-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  Differential expression of central metabotropic glutamate receptor (mGluR) subtypes in a clinical model of post-surgical pain.

Authors:  Sharron Dolan; James G Kelly; Ana M Monteiro; Andrea M Nolan
Journal:  Pain       Date:  2004-07       Impact factor: 6.961

Review 2.  The gap junction cellular internet: connexin hemichannels enter the signalling limelight.

Authors:  W Howard Evans; Elke De Vuyst; Luc Leybaert
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

3.  The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43.

Authors:  Thomas C Clarke; Dafydd Thomas; Jørgen S Petersen; W Howard Evans; Patricia E M Martin
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.

Authors:  Stephan Weng; Melani Lauven; Thomas Schaefer; Lioudmila Polontchouk; Rajiv Grover; Stefan Dhein
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

5.  Human atrial conduction and arrhythmogenesis correlates with conformational exposure of specific epitopes on the connexin40 carboxyl tail.

Authors:  Prapa Kanagaratnam; Emmanuel Dupont; Stephen Rothery; Steven Coppen; Nicholas J Severs; Nicholas S Peters
Journal:  J Mol Cell Cardiol       Date:  2006-05       Impact factor: 5.000

6.  Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.

Authors:  Mark S Turner; Guy A Haywood; Peter Andreka; Lijing You; Patricia E Martin; W Howard Evans; Keith A Webster; Nanette H Bishopric
Journal:  Circ Res       Date:  2004-09-09       Impact factor: 17.367

7.  Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings.

Authors:  Joanna Jozwiak; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-24       Impact factor: 3.000

8.  Negative growth control of HeLa cells by connexin genes: connexin species specificity.

Authors:  M Mesnil; V Krutovskikh; C Piccoli; C Elfgang; O Traub; K Willecke; H Yamasaki
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

9.  Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes.

Authors:  Bradley W Doble; Xitong Dang; Peipei Ping; Robert R Fandrich; Barbara E Nickel; Yan Jin; Peter A Cattini; Elissavet Kardami
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

10.  Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368.

Authors:  Theresa S Richards; Clarence A Dunn; William G Carter; Marcia L Usui; John E Olerud; Paul D Lampe
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

View more
  8 in total

Review 1.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

Review 2.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

3.  Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function.

Authors:  Scott R Johnstone; Angela K Best; Catherine S Wright; Brant E Isakson; Rachel J Errington; Patricia E Martin
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

4.  Novel pharmacological approaches for antiarrhythmic therapy.

Authors:  Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-01-15       Impact factor: 3.000

5.  Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations.

Authors:  Jennifer A Easton; Steven Donnelly; Miriam A F Kamps; Peter M Steijlen; Patricia E Martin; Gianluca Tadini; René Janssens; Rudolf Happle; Michel van Geel; Maurice A M van Steensel
Journal:  J Invest Dermatol       Date:  2012-05-17       Impact factor: 8.551

6.  Connexin 43 Functions as a Positive Regulator of Stem Cell Differentiation into Definitive Endoderm and Pancreatic Progenitors.

Authors:  Wendy Yang; Paul D Lampe; Patricia Kensel-Hammes; Jennifer Hesson; Carol B Ware; Laura Crisa; Vincenzo Cirulli
Journal:  iScience       Date:  2019-07-24

Review 7.  Mechanisms of Connexin Regulating Peptides.

Authors:  D Ryan King; Meghan W Sedovy; Xinyan Leng; Jianxiang Xue; Samy Lamouille; Michael Koval; Brant E Isakson; Scott R Johnstone
Journal:  Int J Mol Sci       Date:  2021-09-22       Impact factor: 5.923

8.  Gap junctional communication is involved in differentiation of osteoclasts from bone marrow and peripheral blood monocytes.

Authors:  Elina Kylmäoja; Miho Nakamura; Hanna Kokkonen-Puuperä; Veli-Pekka Ronkainen; Petri Lehenkari; Juha Tuukkanen
Journal:  Heliyon       Date:  2018-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.